#news #biotech I-Mab’s IL-6 drug hits goal in ulcerative colitis phase 2

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: I-Mab’s IL-6 drug hits goal in ulcerative colitis phase 2 .I-Mab’s IL-6 drug hits goal in ulcerative colitis phase 2
ntaylor
Mon, 04/26/2021 – 08:32

from FierceBiotech: Biotech https://ift.tt/3dRSxQH